{
    "2021-02-09": [
        [
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)拟向猛犸基金会捐赠1300万元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "猛犸基金会",
                        "捐赠",
                        "1300万元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)拟开展外汇衍生品交易业务额度不超50亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "外汇衍生品",
                        "交易业务",
                        "50亿元"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)拟使用不超过15亿元暂时闲置募集资金进行现金管理",
                "features": {
                    "keywords": [
                        "华大基因",
                        "募集资金",
                        "现金管理",
                        "15亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：使用募集资金向子公司增资",
                "features": {
                    "keywords": [
                        "华大基因",
                        "募集资金",
                        "子公司",
                        "增资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "一篇文章盘点：十大具有生物产业链价值的基因公司",
                "features": {
                    "keywords": [
                        "生物产业链",
                        "基因公司",
                        "盘点"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "灵魂砍价杀不死好公司，8000亿医疗器械还是百分百好赛道",
                "features": {
                    "keywords": [
                        "灵魂砍价",
                        "医疗器械",
                        "赛道"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "张磊一年斩获22个医疗企业IPO高瓴资本详解2021年投资方向",
                "features": {
                    "keywords": [
                        "张磊",
                        "高瓴资本",
                        "医疗企业",
                        "IPO",
                        "2021年投资方向"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}